Method Development for Laser-Diffraction Particle-Size Analysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Method Development for Laser-Diffraction Particle-Size Analysis
The author examines the process of method development, with reference to ISO 13320:2009 and relevant monographs from the United States and European pharmacopoeias.


Pharmaceutical Technology
pp. 100-106

References

1. ISO 13320:2009 Particle Size Analysis—Laser Diffraction Methods. Part 1: General Principles (2009).

2. USP30–NF25 General Chapter <429>, "Light Diffraction Measurement of Particle Size," pp. 1235–1241.

3. ISO 14488:2007 Particulate materials—Sampling and sample splitting for the determination of particulate properties.

4. Application note MRK373: The Use of Zeta Potential Measurements for Improving Dispersion During Particle Size Measurements, http://www.malvern.com/appnote_particle_size_determination, accessed Sept. 18, 2010.

5. ISO 14887:2000 Sample Preparation—Dispersing procedures for powders in liquids (2000).

6. Ph.Eur. 6.6 General Chapter 2.9.31, "Laser Diffraction Measurement of Particle Size," (EDQM, Strasbourg, France) p. 5103.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here